About MedyFin

With over 20 years of business experience, we are a group of investors who currently own 75% of MedyFin’s equity. Based in Switzerland, we prioritize profitable companies that generate early cash flow. The competitive advantage of MedyFin can be described through five principles:

​

a) Operating in an industry with robust growth evidence across demographics, regulations, and market trends over the next decade. 

​

b) Leveraging expert insights to identify companies with significant added value. 

​

c) Evaluating participation levels in each business based on financial metrics, customer experience, market capabilities, management quality, economic conditions, and other measurable factors. 

​

d) Executing trades using a Customized Trading Machine that relies on years of data and executes trades in milliseconds. 

​

e) Working with regulated premium banks and brokers, MedyFin allows you to easily invest in Healthcare companies.

​

Currently, MedyFin is inviting investors to come on board and be a part of this fast-growing industry. With only 25% of the shares remaining, you could now own a successful business in a thriving industry.